Effect of Vitamin D Treatment on Serum Sclerostin Level

ACIBUCU F., Dokmetas H. S., Acibucu D. O., Kilicli F., Aydemir M., ÇAKMAK E.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.125, sa.9, ss.634-637, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 125 Sayı: 9
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1055/s-0035-1559790
  • Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.634-637
  • Anahtar Kelimeler: sclerostin, vitamin D deficiency, parathyroid hormone, PARATHYROID-HORMONE, BONE-FORMATION, PRIMARY HYPERPARATHYROIDISM, CIRCULATING SCLEROSTIN, POSTMENOPAUSAL WOMEN, OSTEOPOROSIS, SOST, PTH, TARGET, GENE
  • Akdeniz Üniversitesi Adresli: Hayır

Özet

Objective Sclerostin is an osteocyte-secreted endogenous inhibitor of Wnt signaling. Several systemic and local factors have been suggested as possible regulators of sclerostin expression by osteocytes. In this study, we examined the effect of vitamin D treatment on sclerostin levels.